Myeloma Treatments
The following is a listing of myeloma treatments associated with this tag.
All Treatments
View all treatments in development for myeloma patients around the US.
Untreated / Newly Diagnosed Multiple
Myeloma
The following is a listing of treatments in development for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Early Relapse Multiple Myeloma
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
Late Relapse Multiple Myeloma
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
Myeloma Clinical Trials
The following is a listing of myeloma clinical trials associated with this tag.
All Clinical Trials
View all active clinical trials around the US.
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
CONDENSED BUSULFAN, MELPHALAN, AND FLUDARABINE
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
SHORTENED CHEMOTHERAPY REGIMEN
Verified
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
ANTIBIOTICS DURING STEM CELL TRANSPLANTSparkCures Verified Accurate, up-to-date information. Learn more
A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning
RADIATION-BASED REDUCED INTENSITY CONDITIONINGA Multi-Center, Phase 1 Trial of Combining Anti-CD47 Antibody (Magrolimab) With Azacitidine as Post-Transpl...
MAGROLIMAB AND AZACITIDINE MAINTENANCEA Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Relate...
MISMATCHED RELATED VS. MATCHED UNRELATED DONORA Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufacture...
SAFETY STUDY OF CORD BLOOD UNITSA Phase 1 Study of Adding Venetoclax to a Reduced Intensity Conditioning Regimen and to Maintenance in Comb...
VENETOCLAX IN PRE- AND POST-TRANSPLANT THERAPYA Phase 1/2 Multi-Center Trial of Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents ...
VORINOSTAT FOR GVHD PREVENTIONA Phase I Study of Intensity Modulated Total Marrow Irradiation (IMTMI) in Addition to Fludarabine/Melphala...
INTENSITY MODULATED TOTAL MARROW IRRADIATIONA Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood ...
GRAFT VERSUS HOST DISEASE-REDUCTION STRATEGIESA Phase II Randomized Study to Assess Outcomes With Treosulfan-Based Versus Clofarabine-Based Conditioning ...
TREOSULFAN VS. CLOFARABINE-BASED CONDITIONINGA Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulf...
INTENSITY MODULATED TOTAL MARROW IRRADIATIONA Phase II Trial of Venetoclax-Enhanced Reduced Intensity HLA-Mismatched Allogeneic Transplant for Ultra-Hi...
VENETOCLAX-ENHANCED REDUCED INTENSITY CONDITIONINGA Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoi...
IS-FREE TREG STEM CELL TRANSPLANTAllogeneic Hematopoietic Stem Cell Transplant for Patients With Mutations in GATA2 or the MonoMAC Syndrome
ALLO STEM CELL TRANSPLANT FOR GATA2 MUTATIONSAllogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure...
G-CSF MOBILIZED CD34+ CELLS IN TRANSPLANTCD45RA Depleted Peripheral Stem Cell Addback for Patients at Risk for Viral or Fungal Infections Post TCRαβ...
ADDBACK OF DONOR CD45RA DEPLETED CELLSCLAG-M or FLAG-Ida Chemotherapy Followed Immediately by Related/Unrelated Reduced-Intensity Conditioning (R...
CLAG-M OR FLAG-IDA CHEMOTHERAPYComparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrel...
REGIMENS FOR GRAFT VERSUS HOST PREVENTIONCytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Tran...
CYTOKINE-TREATED VETO CELLS POST-TRANSPLANTHaplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood...
POST-TRANSPLANT CYCLOPHOSPHAMIDEInfusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of ...
CORD BLOOD TRANSPLANT WITH DILANUBICELMatched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha...
TARGETED ATG DOSING PILOT STUDYMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTPhase 2a Study of Adding Ruxolitinib With Tacrolimus/Methotrexate Regimen for Graft-versus-Host Disease Pro...
RUXOLITINIB FOR GVHD PREVENTIONPhase II Study of Evaluating the Efficacy of Total Marrow and Lymphoid Irradiation (TMLI) as the Conditioni...
TOTAL MARROW AND LYMPHOID IRRADIATIONPhase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood ...
A/B TCD PERIPHERAL BLOOD STEM CELL TRANSPLANTATIONPlacebo-Controlled and Randomized Phase 2 Trial of CMV-MVA Triplex Vaccination in HLA-Matched Related Stem ...
CMV-MVA TRIPLEX VACCINATIONReduced Intensity, Partially HLA Mismatched Allogeneic BMT for Hematologic Malignancies Using Donors Other ...
PARTIALLY MISMATCHED STEM CELL TRANSPLANTSafety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITSSingle Center Pilot Study to Investigate the Efficacy of Adding Itacitinib to Post-Transplant Cyclophospham...
ITACITINIB FOR GVHD PREVENTIONTCR-αβ+ and CD19+ Depleted KIR/KIR Ligand-mismatched Haploidentical Hematopoietic Stem Cell Transplant and ...
TCRαβ+/CD19+ DEPLETED HAPLOIDENTICAL HSCTUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANTSparkCures Verified Accurate, up-to-date information. Learn more
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITS²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
CONDENSED BUSULFAN, MELPHALAN, AND FLUDARABINE
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
SHORTENED CHEMOTHERAPY REGIMENSparkCures Verified Accurate, up-to-date information. Learn more
Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Tran...
CYTOKINE-TREATED VETO CELLS POST-TRANSPLANTMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTSafety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITSUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Verified
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)
BONE MARROW & KIDNEY TRANSPLANT
Verified
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
SHORTENED CHEMOTHERAPY REGIMENSparkCures Verified Accurate, up-to-date information. Learn more
Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Tran...
CYTOKINE-TREATED VETO CELLS POST-TRANSPLANTMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTSafety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Progra...
INVESTIGATIONAL CORD BLOOD UNITSUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREP²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials